Robuta

https://pmc.ncbi.nlm.nih.gov/articles/PMC11615905/ Autologous mitochondrial transplant for acute cerebral ischemia: Phase 1 trial results and review -... The results of a Phase 1 trial of autologous mitochondrial transplantation for the treatment of acute ischemic stroke during mechanical thrombectomy are... phase 1 trial https://www.news-medical.net/news/20100817/Palatin-reports-positive-results-from-bremelanotide-Phase-1-trial-for-sexual-dysfunction.aspx Palatin reports positive results from bremelanotide Phase 1 trial for sexual dysfunction Sep 7, 2014 - Palatin Technologies, Inc. today announced positive results of a Phase 1 clinical trial of subcutaneously administered bremelanotide, its melanocortin agonist... phase 1 trialpositive results https://www.news-medical.net/news/20250618/New-switchable-CAR-T-therapy-enters-phase-1-trial-for-advanced-breast-cancer.aspx New switchable CAR-T therapy enters phase 1 trial for advanced breast cancer Jun 18, 2025 - The Calibr-Skaggs Institute for Innovative Medicines, the drug development division of Scripps Research, today announced a milestone in cancer treatment with... car t therapyphase 1 trial https://www.biospace.com/monopar-announces-first-patient-enrolled-in-first-in-human-phase-1-trial-for-its-novel-radiopharmaceutical-mnpr-101-zr Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel... phase 1 trial https://www.cbsnews.com/video/moderna-announces-positive-phase-1-trial-data-for-coronavirus-vaccine/ Moderna announces positive Phase 1 trial data for coronavirus vaccine - CBS News The biotech firm Moderna Therapeutics announced that the first eight participants in the Phase 1 of its COVID-19 vaccine trial developed some antibodies after... phase 1 trial https://www.prnewswire.com/news-releases/phase-1-trial-demonstrates-encouraging-clinical-benefit-and-promising-safety-profile-of-pacritinib-for-the-prevention-of-graft-versus-host-disease-published-in-clinical-cancer-research-301252886.html Phase 1 Trial Demonstrates Encouraging Clinical Benefit and Promising Safety Profile of Pacritinib... /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), today announced that Clinical Cancer Research, a journal of the American Association for Cancer Research,... phase 1 trial https://www.biospace.com/press-releases/anixa-biosciences-announces-completion-of-enrollment-in-phase-1-trial-of-breast-cancer-vaccine Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine -... phase 1 trial https://www.marketscreener.com/news/avacta-opens-phase-1-trial-for-conjugate-s-efficacy-regarding-tumours-ce7e5edadd80f12c Avacta opens phase 1 trial for conjugate's efficacy regarding tumours | MarketScreener Mar 16, 2026 - Avacta Group PLC on Monday announced the opening of a phase 1 trial for AVA6103, a peptide-drug conjugate. The London-based life sciences company said the... phase 1 trial https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2025/11/23/20/14/CRISPR-Cas9 Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 - American College of Cardiology crispr cas9 gene editingphase 1 trial https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-first-phase-1-trial-results-of-a-candidate-ebola-vaccine/ GSK statement on first phase 1 trial results of a candidate Ebola vaccine | GSK Results from phase 1 trial published in NEJM show that GSK/NIH Ebola candidate vaccine was well-tolerated in the 20 healthy adult volunteers phase 1 trial https://www.asiae.co.kr/en/article/bio-health/2026031615243829690 Organoid Science Receives IND Approval for Phase 1 Trial of Organoid-Based Regenerative Therapy -... Mar 16, 2026 - Organoid Science announced on March 16 that the Ministry of Food and Drug Safety has approved its IND (Investigational New Drug) application for a Pha phase 1 trial https://axisclinicalsusa.com/ Clinical Research Center for Phase 1 Clinical Trials | Early Phase Trial Unit Trusted clinical research center offering Phase I trials, early phase 1 clinical trials, and complete early phase clinical development services through a... clinical research centerphase 1trialsearlyunit https://www.businesswire.com/news/home/20201201005539/en/Turnstone-Biologics-Announces-First-Patients-Enrolled-in-Phase-12-Clinical-Trial-Evaluating-RIVAL-01-For-the-Treatment-of-Solid-Tumors Turnstone Biologics Announces First Patients Enrolled in Phase 1/2 Clinical Trial Evaluating... Turnstone Biologics Corp., a clinical-stage biotechnology company pioneering the development of engineered viral immunotherapies, today announced enrollment ... https://www.biospace.com/bioinvent-and-transgene-first-patient-treated-in-part-b-of-phase-1-trial-assessing-the-novel-oncolytic-virus-bt-001-in-combination-with-keytruda-pembrolizumab BioInvent and Transgene: First patient treated in Part B of Phase 1 trial assessing the novel... Oct 10, 2023 - BioInvent International AB and Transgene announce that that the first patient of the Phase 1 part B clinical trial evaluating the combination of BT-001 and... https://www.biospace.com/elevation-oncology-expands-ongoing-phase-1-clinical-trial-of-eo-3021-globally-dosing-first-patient-in-japan Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient... Feb 22, 2024 - Elevation Oncology, Inc. today announced that it has expanded its ongoing Phase 1 clinical trial of EO-3021 outside the United States, dosing the first patient... phase 1 clinical trial https://www.biospace.com/press-releases/lyell-immunopharma-announces-oral-presentation-of-new-clinical-data-from-the-phase-1-2-trial-of-lyl314-for-the-treatment-of-large-b-cell-lymphoma-at-the-international-conference-on-malignant-lymphoma-icml-2025 Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of...